The interaction of taxol and vinblastine with radiation induction of p53 and p21(WAF1/CIP1)

British Journal of Cancer

Volumn 74, Issue SUPPL. XXVII, 1996, Pages

  Tishler, R B ^a   Lamppu, D M ^a  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

Author keywords

p21; p53; Radiation; Taxol; Vinblastine

Indexed keywords

ANTIINFECTIVE AGENT; PACLITAXEL; PROTEIN P21; PROTEIN P53; VINBLASTINE; ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; MICROTUBULE; MOUSE; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RADIATION; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL STRAIN 3T3; DNA DAMAGE; DRUG EFFECT; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; RADIATION EXPOSURE;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASE SEQUENCE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; MICE; MOLECULAR SEQUENCE DATA; PACLITAXEL; TUMOR SUPPRESSOR PROTEIN P53; VINBLASTINE;

EID: 0029888728     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. CALABRESI P AND CHABNER BA. (1990). Chemotherapy of Neoplastic Diseases. In Goodman & Gilman's The Pharmacological Basis of Therapeutics. Goodman AG, Rall TW, Nies AS and Taylor P. (eds), 8th ed., pp. 1202-1263. Pergammon Press: New York.
2. CHOY H, AKERLEY W, SAFRAN H, CLARK J, REGE V, PAPA A, GLANTZ M, PUTHAWALA Y, SODERBERG C AND LEONE L. (1994). Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. J. Clin. Oncol., 12, 2682-2686.
3. CLARKE AR, PURDIE CA, HARRISON DJ, MORRIS RG, BIRD CC, HOOPER ML AND WYLIE AH. (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849-851.
4. CROSS SW, SANCHEZ CA, MORGAN CA, SCHMIKE MK, RAMEL S, IDZERDA RL, RASKIND WH AND REID BJ. (1995). A p53-dependent mouse spindle checkpoint. Science, 267, 1353-1356.
5. EL-DEIRY WS, TOKINO T, VELCULESCU VE, LEVY DB, PARSONS R, TRENT, LIN D, MERCER WE, KINZLER KW AND VOGELSTEIN B. (1993). WAF1, a potential mediator of p53 tumour suppression. Cell, 75, 817-825.
6. FRITSCHE M, HAESSLER C AND BRANDER G. (1993). Induction of nuclear accumulation of the tumour suppressor protein p53 by DNA-damaging agents. Oncogene, 8, 307-318.
7. FUNK WD, PAK DT, KARAS RH, WRIGHT WE AND SHAY JW. (1992). A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol., 12, 2866-2871.
8. HARPER JW, ADAMI GR, WEI N, KEYOMARSI K AND ELLEDGE SJ. (1993). The p21 Cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
9. JOSCHKO MA, WEBSTER LK, GROVES J, BALL DL AND BISHOP JP. (1994). Radiation enhancement by taxol in squamous carcinoma of the hypopharynx (FaDu) in nude mice. Proc. Am. Assoc. Cancer Res., 35, 674.
10. KASTAN MB, ONYEKWERE O, SIDRANSKY D, VOGELSTEIN B AND CRAIG RW. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
11. KUERBTIZ SJ, PLUNKETT BS, WALSH WV AND KASTAN MB. (1992). Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl Acad. Sci. USA, 89, 7491-7495.
12. LIEBMAN JE, COOK JA, FISHER J, TEAGUE D AND MITCHELL JB. (1994). In vitro studies of taxol as a radiation sensitizer in human tumour cells. J. Natl Cancer Inst., 86, 441-446.
13. LOWE SW, RULEY HW, JACKS T AND HOUSMAN DE. (1993a). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
14. LOWE SW, SCHMITT EM, SMITH SW, OSBORNE BA AND JACKS T. (1993b). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
15. LOWE SW, BODIS S, MCCLATCHEY A, REMINGTON L, RULEY HE, FISHER DE, HOUSMAN DE AND JACKS T. (1994). p53 Status and the efficacy of cancer therapy in vivo. Science, 266, 807-810.
16. MILAS L, HUNTER NR, MASON KA, KURDOGLU B AND PETERS LJ. (1994). Enhancement of tumor radioresponse of a murine mammary carcinoma by taxol. Cancer Res., 54, 3506-3510.
17. MILAS L, HUNTER NR, MASON KA, MILROSS CG, SAITO Y AND PETERS LJ. (1995). Role of reoxygenation in induction of enhancement of tumour response by paclitaxel. Cancer Res., 35, 3564-3568.
18. NELSON WG AND KASTAN ME. (1994). DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA response pathways. Mol. Cell. Biol., 14, 1815-1823.
19. (+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res., 55, 1643-1648.
20. 2+ is essential for multistep activation of the heat shock factor in permeabilized cells. Mol. Cell. Biol., 6, 3365-3368.
21. PRICE BD AND CALDERWOOD SK. (1993). Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene, 8, 3055-3062.
22. RUSSELL KJ, WIENS LW, DEMERS WG, GALLOWAY DA, PLON SE AND GROUDINE M. (1995). Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res., 55, 1639-1642.
23. SCHIFF PB AND HORWITZ SB. (1980). Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl Acad. Sci. USA, 77, 1561-1565.
24. TISHLER RB, GEARD CR, HALL EJ AND SCHIFF PB. (1992a). Taxol sensitizes human astrocytoma cells to radiation. Cancer Res., 52, 3495-3497.
25. TISHLER RB, SCHIFF PB, GEARD CR AND HALL EJ. (1992b). Taxol: a novel radiation sensitizer. Int. J. Radiat. Oncol. Biol. Phys., 22, 613-617.
26. TISHLER RB, CALDERWOOD SK, COLEMAN CN AND PRICE BD. (1993). Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res., 53, 2212-2216.
27. TISHER RB, LAMPPU DM, PARK S AND PRICE BD. (1995). The microtubule active drugs taxol, vinblastine and nocodazole increase the levels of transcriptionally active p53. Cancer Res., 55, 6021-6025.
28. ZAMBETTI GP, BARGONETTI J, WALKER K, PRIVES C AND LEVINE AJ. (1992). Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes and Develop., 6, 1143-1152.
29. ZHEN W, LOVISCEK K, WALTER S, GENG L, DENAULT CM AND VAUGHN ATM. (1995). The p53 gene product influences radiosensitivity, but not sensitivity to Taxol, in lymphoblastoid cell lines of common origin. Proc. Am. Assoc. Cancer Res., 36, 14.